Acute graft versus host disease
Mesenchymal stromal cells for acute graft-versus-host disease: response at 1 week predicts probability of survival.
5
Acute graft versus host disease after orthotopic liver transplantation
6
Pathophysiology, prevention, and treatment of acute graft-versus-host disease
14
Correlation of T-Cell Subsets and Hypercholesterolemia of the Donor and Its Association with Acute Graft-versus-Host Disease
6
Acute graft versus host disease
9
<p>Decitabine-Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft versus Host Disease</p>
9
HIF 1α inhibitor echinomycin reduces acute graft versus host disease and preserves graft versus leukemia effect
11
The paranasal sinuses of patients with acute graft versus host disease
5
Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethality
21
Regulation of human immunoglobulin E synthesis in acute graft versus host disease
10
Early myeloid-derived suppressor cells (HLA-DR−/lowCD33+CD16−) expanded by granulocyte colony-stimulating factor prevent acute graft-versus-host disease (GVHD) in humanized mouse and might contribute to lower GVHD in patients post allo-HSCT
16
Review Article Association of gut decontamination and graft versus host disease in allogeneic hematopoietic stem cell transplantation: a meta-analysis
8
Original Article Effects of regulatory dendritic cells on graft-versus-host disease and graft-versus-leukemia in mice after allogeneic bone marrow transplantation
11
Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party
11
Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study
11
Prophylaxis and treatment of acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation
8
Prognostic factors and outcome of patients undergoing hematopoietic stem cell transplantation who are admitted to pediatric intensive care unit
5
The gut microbiota and graft versus host disease
11
Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease—a meta-analysis
12
A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia
8